Insider Transactions

What Veracyte, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

	3 months	12 months
Open-market buys	0	0
Sells	10	58
Total trades	16	119

Shares traded

	3 months	12 months
Acquired	0	959,794
Disposed	57,320	687,752
Net activity	−57,320	+272,042

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

All Buys Sells

Insider	Relation	Date	Transaction	Shares	Price	Value	Shares held
Bhanji Muna	Director	Oct 19	Open-market sale · S	−1,864	$43.70	−$81.5K	40,854
Leite John	Global Chief Commercial Off	Sep 21	Open-market sale · S	−4,015	$40.00	−$161K	124,329
Holstein Jens	Director	Sep 14	Open-market sale · S	−5,000	$40.95	−$205K	27,471
McGuire Annie	EVP, General Counsel	Sep 04	Open-market sale · S	−1,100	$43.67	−$48K	131,160
McGuire Annie	EVP, General Counsel	Sep 04	Open-market sale · S	−2,154	$42.79	−$92.2K	132,260
Chambers Rebecca	Chief Financial Officer	Sep 04	Open-market sale · S	−1,175	$43.71	−$51.4K	166,025
Chambers Rebecca	Chief Financial Officer	Sep 04	Open-market sale · S	−2,477	$42.81	−$106K	167,200
Febbo Phillip G.	Chief Scientific & Med Officer	Sep 04	Open-market sale · S	−2,705	$43.66	−$118K	133,048
Febbo Phillip G.	Chief Scientific & Med Officer	Sep 04	Open-market sale · S	−10,405	$42.89	−$446K	135,753
Wygant Jonathan	VP, Chief Accounting Officer	Sep 02	Withheld — tax / exercise cost · F	−1,361	$44.88	−$61.1K	43,226
McGuire Annie	EVP, General Counsel	Sep 02	Withheld — tax / exercise cost · F	−3,215	$44.88	−$144K	134,414
Stapley Marc	Chief Executive Officer	Sep 02	Withheld — tax / exercise cost · F	−8,782	$44.88	−$394K	432,073
Chambers Rebecca	Chief Financial Officer	Sep 02	Withheld — tax / exercise cost · F	−3,603	$44.88	−$162K	169,677
Febbo Phillip G.	Chief Scientific & Med Officer	Sep 02	Withheld — tax / exercise cost · F	−3,639	$44.88	−$163K	146,158
Leite John	Global Chief Commercial Off	Sep 02	Withheld — tax / exercise cost · F	−3,961	$44.88	−$178K	128,344
Bhanji Muna	Director	Sep 01	Open-market sale · S	−1,864	$42.97	−$80.1K	42,718
Eastham Karin	Director	Jun 18	Open-market sale · S	−529	$53.55	−$28.3K	15,097
Eastham Karin	Director	Jun 18	Open-market sale · S	−3,200	$52.78	−$169K	15,626
Shafer David Brent	Director	Jun 11	Grant / award · A	+5,272	—	—	31,100
Barr Eliav	Director	Jun 11	Grant / award · A	+5,272	—	—	56,461

Page 1 of 49 · showing the 20 most recent Sign up free to view all 968 transactions and filter by insider →

Comments